Persistent Response to a Combination Treatment Featuring a Targeted Agent and an Immune Checkpoint Inhibitor in a Patient With Collecting Duct Renal Carcinoma: A Case Report and Literature Review

Collecting duct carcinoma (CDC) is a rare and highly aggressive subtype of kidney cancer that is associated with a poor prognosis. At present, there is no effective treatment for CDC. Herein, we report a case of metastatic CDC treated with a combination of a tyrosine kinase inhibitor and an immune c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Weimin, Huang, Ji, He, Qiuming, Luo, Qingfeng, Zhang, Xiaofang, Tao, Xuewei, Dong, Hanzhi, Tu, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606665/
https://www.ncbi.nlm.nih.gov/pubmed/34820330
http://dx.doi.org/10.3389/fonc.2021.764352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606665/
https://www.ncbi.nlm.nih.gov/pubmed/34820330
http://dx.doi.org/10.3389/fonc.2021.764352

Ejemplares similares